Patients on Cymbalta experienced a statistically longer time to relapse of depression than did patients on placebo. Relapse was defined as an increase of two or more points on the Clinical Global ...

INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta(R) (duloxetine HCl) for the maintenance treatment of ...

INDIANAPOLIS, July 6, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...

surged Wednesday after the Indianapolis-based drug company said the federal government had given conditional approval for its antidepressant Cymbalta. The conditions outlined by the Food and Drug ...

It could be another Prozac moment. Eli Lilly and Co. is pitching its next star antidepressant drug, Cymbalta, for approval to treat the poorly understood pain of fibromyalgia. Regulators OK’d a drug ...

Over 230,000 bottles of the antidepressant duloxetine (Cymbalta) have been recalled due to the presence of a potential carcinogen. (USA Today) In an exploratory analysis of two phase III trials, ...

Cymbalta is approved to treat major depressive disorder and generalized anxiety disorder, and to manage diabetic peripheral neuropathic pain and fibromyalgia. Cymbalta is also approved for the ...

ROCKVILLE, Md., July 5-Adults using antidepressants may have an increased risk of suicidal behavior, especially when initiating treatment or when changing doses, said the FDA. In a Public Health ...

In everyday language, the word depression is used in diverse ways and can refer to anything from passing feelings of sadness and unhappiness to chronic grief and deep despair. When clinicians and ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...